Prevalence of the dhfr and dhps mutations among pregnant women in rural Burkina Faso five years after the introduction of intermittent preventive treatment with sulfadoxine-pyrimethamine

Marc C Tahita, Halidou Tinto, Annette Erhart, Adama Kazienga, Robert Fitzhenry, Chantal Van Overmeir, Anna Rosanas-Urgell, Jean-Bosco Ouedraogo, Robert T Guiguemde, Jean-Pierre Van Geertruyden, Umberto D'Alessandro

Research output: Contribution to journalA1: Web of Science-article

9 Downloads (Pure)

Abstract

BACKGROUND: The emergence and spread of drug resistance represents one of the biggest challenges for malaria control in endemic regions. Sulfadoxine-pyrimethamine (SP) is currently deployed as intermittent preventive treatment in pregnancy (IPTp) to prevent the adverse effects of malaria on the mother and her offspring. Nevertheless, its efficacy is threatened by SP resistance which can be estimated by the prevalence of dihydropteroate synthase (dhps) and dihydrofolate reductase (dhfr) mutations. This was measured among pregnant women in the health district of Nanoro, Burkina Faso.

METHODS: From June to December 2010, two hundred and fifty six pregnant women in the second and third trimester, attending antenatal care with microscopically confirmed malaria infection were invited to participate, regardless of malaria symptoms. A blood sample was collected on filter paper and analyzed by PCR-RFLP for the alleles 51, 59, 108, 164 in the pfdhfr gene and 437, 540 in the pfdhps gene.

RESULTS: The genes were successfully genotyped in all but one sample (99.6%; 255/256) for dhfr and in 90.2% (231/256) for dhps. The dhfr C59R and S108N mutations were the most common, with a prevalence of 61.2% (156/255) and 55.7% (142/255), respectively; 12.2% (31/255) samples had also the dhfr N51I mutation while the I164L mutation was absent. The dhps A437G mutation was found in 34.2% (79/231) isolates, but none of them carried the codon K540E. The prevalence of the dhfr double mutations NRNI and the triple mutations IRNI was 35.7% (91/255) and 11.4% (29/255), respectively.

CONCLUSION: Though the mutations in the pfdhfr and pfdhps genes were relatively common, the prevalence of the triple pfdhfr mutation was very low, indicating that SP as IPTp is still efficacious in Burkina Faso.

Original languageEnglish
JournalPLoS ONE
Volume10
Issue number9
Pages (from-to)e0137440
Number of pages9
ISSN1932-6203
DOIs
Publication statusPublished - 2015

Fingerprint

Dive into the research topics of 'Prevalence of the <em>dhfr</em> and <em>dhps</em> mutations among pregnant women in rural Burkina Faso five years after the introduction of intermittent preventive treatment with sulfadoxine-pyrimethamine'. Together they form a unique fingerprint.

Cite this